133 related articles for article (PubMed ID: 9864049)
1. The anti-herpes simplex virus activity of n-docosanol includes inhibition of the viral entry process.
Pope LE; Marcelletti JF; Katz LR; Lin JY; Katz DH; Parish ML; Spear PG
Antiviral Res; 1998 Dec; 40(1-2):85-94. PubMed ID: 9864049
[TBL] [Abstract][Full Text] [Related]
2. Synergistic inhibition of herpesvirus replication by docosanol and antiviral nucleoside analogs.
Marcelletti JF
Antiviral Res; 2002 Nov; 56(2):153-66. PubMed ID: 12367721
[TBL] [Abstract][Full Text] [Related]
3. Herpes simplex virus type 1 entry is inhibited by the cobalt chelate complex CTC-96.
Schwartz JA; Lium EK; Silverstein SJ
J Virol; 2001 May; 75(9):4117-28. PubMed ID: 11287561
[TBL] [Abstract][Full Text] [Related]
4. Anti-herpes simplex virus activity of n-docosanol correlates with intracellular metabolic conversion of the drug.
Pope LE; Marcelletti JF; Katz LR; Katz DH
J Lipid Res; 1996 Oct; 37(10):2167-78. PubMed ID: 8906594
[TBL] [Abstract][Full Text] [Related]
5. Nectin-2-mediated entry of a syncytial strain of herpes simplex virus via pH-independent fusion with the plasma membrane of Chinese hamster ovary cells.
Delboy MG; Patterson JL; Hollander AM; Nicola AV
Virol J; 2006 Dec; 3():105. PubMed ID: 17192179
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activity of 1-docosanol, an inhibitor of lipid-enveloped viruses including herpes simplex.
Katz DH; Marcelletti JF; Khalil MH; Pope LE; Katz LR
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10825-9. PubMed ID: 1660151
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of herpes simplex type 1 and type 2 infections by Oximacro(®), a cranberry extract with a high content of A-type proanthocyanidins (PACs-A).
Terlizzi ME; Occhipinti A; Luganini A; Maffei ME; Gribaudo G
Antiviral Res; 2016 Aug; 132():154-64. PubMed ID: 27321663
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of herpes simplex virus in culture by oligonucleotides composed entirely of deoxyguanosine and thymidine.
Fennewald SM; Mustain S; Ojwang J; Rando RF
Antiviral Res; 1995 Jan; 26(1):37-54. PubMed ID: 7741520
[TBL] [Abstract][Full Text] [Related]
9. Houttuynia cordata targets the beginning stage of herpes simplex virus infection.
Hung PY; Ho BC; Lee SY; Chang SY; Kao CL; Lee SS; Lee CN
PLoS One; 2015; 10(2):e0115475. PubMed ID: 25643242
[TBL] [Abstract][Full Text] [Related]
10. Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro.
Schuhmacher A; Reichling J; Schnitzler P
Phytomedicine; 2003; 10(6-7):504-10. PubMed ID: 13678235
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol inhibition of herpes simplex virus replication.
Docherty JJ; Fu MM; Stiffler BS; Limperos RJ; Pokabla CM; DeLucia AL
Antiviral Res; 1999 Oct; 43(3):145-55. PubMed ID: 10551373
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of an aqueous Pelargonium sidoides extract against herpesvirus.
Schnitzler P; Schneider S; Stintzing FC; Carle R; Reichling J
Phytomedicine; 2008 Dec; 15(12):1108-16. PubMed ID: 18691858
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of Spirogyra spp. algal extracts against herpes simplex virus type 1 and 2 infection.
Deethae A; Peerapornpisal Y; Pekkoh J; Sangthong P; Tragoolpua Y
J Appl Microbiol; 2018 Jun; 124(6):1441-1453. PubMed ID: 29532624
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol suppresses nuclear factor-kappaB in herpes simplex virus infected cells.
Faith SA; Sweet TJ; Bailey E; Booth T; Docherty JJ
Antiviral Res; 2006 Dec; 72(3):242-51. PubMed ID: 16876885
[TBL] [Abstract][Full Text] [Related]
15. Syncytial Mutations Do Not Impair the Specificity of Entry and Spread of a Glycoprotein D Receptor-Retargeted Herpes Simplex Virus.
Okubo Y; Uchida H; Wakata A; Suzuki T; Shibata T; Ikeda H; Yamaguchi M; Cohen JB; Glorioso JC; Tagaya M; Hamada H; Tahara H
J Virol; 2016 Dec; 90(24):11096-11105. PubMed ID: 27707922
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic Inactivation of Herpes Simplex Viruses.
Monjo AL; Pringle ES; Thornbury M; Duguay BA; Monro SMA; Hetu M; Knight D; Cameron CG; McFarland SA; McCormick C
Viruses; 2018 Sep; 10(10):. PubMed ID: 30274257
[TBL] [Abstract][Full Text] [Related]
17. Use of chimeric nectin-1(HveC)-related receptors to demonstrate that ability to bind alphaherpesvirus gD is not necessarily sufficient for viral entry.
Geraghty RJ; Fridberg A; Krummenacher C; Cohen GH; Eisenberg RJ; Spear PG
Virology; 2001 Jul; 285(2):366-75. PubMed ID: 11437670
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of herpes simplex virus type 1 entry by chloride channel inhibitors tamoxifen and NPPB.
Zheng K; Chen M; Xiang Y; Ma K; Jin F; Wang X; Wang X; Wang S; Wang Y
Biochem Biophys Res Commun; 2014 Apr; 446(4):990-6. PubMed ID: 24657267
[TBL] [Abstract][Full Text] [Related]
19. The polysulfonated compound suramin blocks adsorption and lateral difusion of herpes simplex virus type-1 in vero cells.
Aguilar JS; Rice M; Wagner EK
Virology; 1999 May; 258(1):141-51. PubMed ID: 10329576
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of virus-encoded thymidine kinase suppresses herpes simplex virus replication in vitro and in vivo.
Watkins AM; Dunford PJ; Moffatt AM; Wong-Kai-In P; Holland MJ; Pole DS; Thomas GM; Martin J; Roberts NA; Mulqueen MJ
Antivir Chem Chemother; 1998 Jan; 9(1):9-18. PubMed ID: 9875372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
